AI-Based Prediction of Drug–Patient Response for Personalized Diabetes Pharmacotherapy
Type 2 diabetes mellitus is a heterogeneous metabolic disorder in which patients exhibit substantial inter-individual variation in therapeutic response. Although multiple pharmacological classes are available, treatment selection is frequently guided by population-level evidence and sequential therapeutic adjustment, w...